OTCMKTS:EROX Human Pheromone Sciences (EROX) Stock Price, News & Analysis $0.0004 0.00 (0.00%) As of 09/26/2022 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Human Pheromone Sciences Stock (OTCMKTS:EROX) Get EROX alerts:Sign Up Key Stats Today's Range$0.0004▼$0.000450-Day Range N/A52-Week Range$0.00▼$0.13VolumeN/AAverage Volume13,574 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Human Pheromone Sciences, Inc., doing business as EROX, is a development‐stage company focused on the research, development and commercialization of consumer products based on human pheromone science. The company’s core business activity centers on formulating and marketing topical fragrances and perfumes that incorporate proprietary pheromone blends intended to enhance personal appeal. Its product lines are designed for direct‐to‐consumer sale through e‐commerce platforms and selected retail partnerships. In addition to finished personal care products, Human Pheromone Sciences pursues formulation and licensing agreements that leverage its in-house expertise in volatile compound chemistry. The company holds or licenses patents and trademarks related to its pheromone delivery systems and works with contract manufacturers to ensure consistent quality and scalability. While still in early stages of market penetration, EROX aims to expand its portfolio beyond fragrances into adjacent wellness categories that utilize pheromone technology. Headquartered in Delaware, Human Pheromone Sciences currently serves primarily the North American market but has indicated plans to explore distribution channels in Europe and Asia as part of its longer-term growth strategy. Although publicly traded on the OTC Pink market under the ticker EROX, detailed information on executive leadership and financial metrics remains limited. As a niche player in the personal care sector, the company continues to develop both its research pipeline and consumer-facing brands in pursuit of broader market adoption.AI Generated. May Contain Errors. Read More Receive EROX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Human Pheromone Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EROX Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com EROX Stock Analysis - Frequently Asked Questions How have EROX shares performed this year? Human Pheromone Sciences' stock was trading at $0.0004 at the start of the year. Since then, EROX stock has increased by 0.0% and is now trading at $0.0004. How do I buy shares of Human Pheromone Sciences? Shares of EROX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/22/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Staples Industry Toilet Preparations Sub-IndustryN/A Current SymbolOTCMKTS:EROX CIKN/A Webwww.naturalattraction.com Phone(408) 938-3030Fax408-938-3025Employees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta3.30 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:EROX) was last updated on 7/22/2026 by MarketBeat.com Staff. From Our PartnersAmerica’s answer to universal basic incomeRobert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTSM just handed Trump's secretive AI project $100 billionTaiwan Semiconductor just committed another $100 billion to U.S. chip manufacturing - on top of $165 billion a...InvestorPlace | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredElon is about to dominate the biggest arms race in tech historyMicrosoft, Amazon, Alphabet, and Meta have collectively poured nearly $700 billion into AI infrastructure in 2...The Oxford Club | SponsoredWall Street legend put 60% in one stock — here’s the tickerOne of America's most famous investors put 60% of his fund into a single stock - and Whitney Tilson of Stansbe...Stansberry Research | SponsoredIt all happens tonight.Tonight, trader Sean Allison is hosting a live session to walk through his Zero-Dollar Trade Advantage strateg...Trade Thirsty | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Human Pheromone Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Human Pheromone Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.